| Company Name: |
Chemsky (shanghai) International Co.,Ltd
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:Chelirubine Chloride
CAS:30044-85-0
Purity:98+% Package:1Mg;5Mg;10Mg;50Mg;100Mg;500Mg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:Chelirubine Chloride
CAS:30044-85-0
Purity:NULL Package:25mg Remarks:NULL
|
| Company Name: |
CLEARSYNTH LABS LTD.
|
| Tel: |
+91-22-45045900 |
| Email: |
sales@clearsynth.com |
| Products Intro: |
Product Name:Chelirubine Chloride
CAS:30044-85-0
|
| Company Name: |
Toronto Research Chemicals
|
| Tel: |
+1 (416) 665-9696 |
| Email: |
info@trc-canada.com |
| Products Intro: |
CAS:30044-85-0
Package:12750USD/25mg
|
|
| | Chelirubine Chloride Basic information |
| | Chelirubine Chloride Chemical Properties |
| Melting point | 280-283 °C (decomp)(Solv: ethanol (64-17-5)) |
| | Chelirubine Chloride Usage And Synthesis |
| Uses | Chelidonine quaternary ammonium reaction product with thiotepa was subjected to a number of pharmacological tests including anticancer activity. These quaternized alkaloids were claimed for use in the treatment of immunological or metabolic dysfunction, cancer, bacterial, fungal and viral infections, radiation damage, epilepsy, multiple sclerosis, skin diseases, postoperative wounds, pain, sleeping disease, herpes infections, influenza virus infections, skin tumors, allergies, chronic fatigue syndrome, osteoporosis, rheumatic diseases, and scars. | | Uses | Chelirubine chloride was claimed for use in the treatment of immunological or metabolic dysfunction, cancer, bacterial, fungal and viral infections, radiation damage, epilepsy, multiple sclerosis, skin diseases, postoperative wounds, pain, sleeping disease, herpes infections, influenza virus infections, skin tumors, allergies, chronic fatigue syndrome, osteoporosis, rheumatic diseases, and scars. |
| | Chelirubine Chloride Preparation Products And Raw materials |
|